TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival  by Inoki, Ken et al.
Cell, Vol. 115, 577–590, November 26, 2003, Copyright 2003 by Cell Press
TSC2 Mediates Cellular Energy Response
to Control Cell Growth and Survival
phosphorylation decreases the ability of TSC2 to inhibit
the phosphorylation of ribosomal S6 kinase (S6K) and
eukaryotic initiation factor 4E binding protein-1 (4EBP1),
Ken Inoki,1,2 Tianqing Zhu,1,2
and Kun-Liang Guan1,2,3,*
1Life Sciences Institute
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Phosphorylation of S6K and 4EBP1 by mTOR play an
important role in the regulation of translation (Brown et
al., 1995; Hara et al., 1998; Shah et al., 2000). TSC1 orSummary
TSC2 mutant cells display elevated phosphorylation of
both S6K and 4EBP1 (Goncharova et al., 2002; KenersonMutations in either the TSC1 or TSC2 tumor suppres-
et al., 2002; Kwiatkowski et al., 2002; Onda et al., 2002).sor gene are responsible for Tuberous Sclerosis Com-
In contrast, overexpression of TSC1 and TSC2 inhibitsplex. The gene products of TSC1 and TSC2 form a
the phosphorylation of S6K and 4EBP1 (Goncharova etfunctional complex and inhibit the phosphorylation of
al., 2002; Inoki et al., 2002; Tee et al., 2002). Together,S6K and 4EBP1, two key regulators of translation.
these results suggest that one of the major cellular func-Here, we describe that TSC2 is regulated by cellular
tions of TSC1/TSC2 is to inhibit translation by inhibitingenergy levels and plays an essential role in the cellular
the phosphorylation of S6K and 4EBP1.energy response pathway. Under energy starvation
The rate of translation is regulated by multiple-signal-conditions, the AMP-activated protein kinase (AMPK)
ing pathways including the availability of nutrients,phosphorylates TSC2 and enhances its activity. Phos-
growth factors, intracellular ATP levels, and environ-phorylation of TSC2 by AMPK is required for transla-
mental stress (Browne and Proud, 2002; Proud, 2002).tion regulation and cell size control in response to
ATP depletion decreases S6K and 4EBP1 phosphoryla-energy deprivation. Furthermore, TSC2 and its phos-
tion and inhibits translation. It has been suggested thatphorylation by AMPK protect cells from energy depri-
mTOR may sense cellular ATP levels because it has avation-induced apoptosis. These observations dem-
high Km (around 1 mM) for ATP (Dennis et al., 2001).onstrate a model where TSC2 functions as a key player
However, this Km value is still considerably lower thanin regulation of the common mTOR pathway of protein
normal cellular ATP levels and therefore a drastic de-synthesis, cell growth, and viability in response to cel-
crease in ATP would be required to affect the activitylular energy levels.
of mTOR (Proud, 2002). AMP is a much more sensitive
indicator for cellular energy status, because cellular ATPIntroduction
concentration is much higher than AMP. A relatively
small decrease in ATP levels will result in a relativelyTuberous sclerosis complex (TSC) is an autosomal dom-
large increase in AMP levels that are sensed by andinant disorder caused by mutation in either the TSC1 or
stimulate the 5AMP-activated protein kinase (AMPK)TSC2 tumor suppressor genes (Young and Povey, 1998).
(Hardie et al., 1998). Therefore, AMPK has been pro-TSC is defined by the formation of hamartomas in a wide
posed as a physiological cellular energy sensor. 2-Deoxyrange of tissues. The TSC1 and TSC2 gene products are
glucose (2DG), a D-glucose analog, and 5-aminoimida-also known as hamartin and tuberin, respectively. They
zole-4-carboxyamide ribonucleotide (AICAR), activate
form a stable functional complex in vivo (van Slegten-
AMPK (Corton et al., 1995) and increase phosphorylation
horst et al., 1998). Recent genetic studies in Drosophila
of the eukaryotic elongation factor 2 (eEF2), indicating
demonstrate that the TSC1/TSC2 complex acts to nega- that AMPK plays a negative role in translation (Horman
tively regulate cell growth and cell size (Gao and Pan, et al., 2002). It has been also reported that both 2DG and
2001; Ito and Rubin, 1999; Potter et al., 2001; Tapon et AICAR inhibit S6K activity (Kimura et al., 2003; Krause et
al., 2001). Homozygous mutation of TSC1 or TSC2 in al., 2002). The mechanism of S6K inhibition by AMPK
mice is embryonic lethal due to cardiac hypertrophy and appears to go through the mTOR pathway (Kimura et
liver hypoplasia, while heterozygous mutation of either al., 2003). However, direct evidence of a molecular link
TSC1 or TSC2 significantly increases tumor incidence between AMPK and mTOR remains to be determined.
(Au et al., 1998; Kobayashi et al., 2001; Kwiatkowski, 2003; In this report, we demonstrate that TSC2 is regulated
Onda et al., 1999). Studies in Drosophila have placed by cellular energy levels. Activation of AMPK by energy
TSC1/TSC2 acting downstream of Akt in the insulin- starvation results in direct phosphorylation of TSC2 on
signaling pathway and upstream of mammalian target T1227 and S1345. Knockdown of TSC2 protein by RNA
of rapamycin (mTOR) (Gao and Pan, 2001; Gao et al., interference eliminates the ATP depletion-induced de-
2002; Potter et al., 2001; Tapon et al., 2001). Biochemical phosphorylation of S6K. In response to energy starva-
studies from several groups have demonstrated that tion, the TSC2/ cells show a defective response in S6K
TSC2 is a direct target of Akt (Dan et al., 2002; Inoki et dephosphorylation. Furthermore, the energy starvation-
al., 2002; Manning et al., 2002; Potter et al., 2002). Akt induced dephosphorylation of S6K is restored by the
expression of wild-type TSC2, but not the AMPK phos-
phorylation mutant in TSC2/ cells, demonstrating a*Correspondence: kunliang@umich.edu
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Figure 1. Effects of Energy Depletion on Phosphorylation of S6K, S6, 4EBP1, mTOR, Akt, AMPK, and TSC2
(A) Dephosphorylation of S6K and 4EBP1 by ATP depletion. HEK293 cells were treated with various agents as indicated for 15 min. Cell
lysates were probed with indicated antibodies for phosphorylation of endogenous proteins.
(B) Mobility shift of TSC2. HEK293 cells were transfected with HA-TSC2 and TSC1. Lysates were resolved by a 5% SDS-PAGE gel and probed
with anti-HA.
(C) 2DG-induces dephosphorylation of endogenous S6K, S6, 4EBP1, mTOR, but not Akt. HEK293 cells were treated with the indicated
concentration of 2DG or mannitol for 15 min. Phosphorylation of endogenous proteins were determined by Western blotting using specific
antibodies or phosphospecific antibodies as indicated on the left of each strip.
(D) 2DG-induces phosphorylation of AMPK.
(E) Time course of 2DG treatment.
(F) Low glucose inhibits S6K. HEK293 cells were cultured in media with indicated concentrations of glucose for 2 hr. All Western blots were
performed with endogenous proteins.
critical function of TSC2 phosphorylation by AMPK in and 4EBP1 (Hara et al., 1998). Interestingly, ATP deple-
tion and nutrients deprivation also resulted in a signifi-the regulation of translation by cellular energy starva-
tion. TSC2 plays an essential role to control cell size in cant mobility upshift of TSC2 (Figure 1B), indicating that
TSC2 phosphorylation is possibly enhanced by theseresponse to energy limitation and to protect cells from
glucose deprivation-induced apoptosis. Moreover, AMPK- cellular conditions.
Dennis et al. (2001) have previously reported that 2DGdependent phosphorylation of TSC2 is important for
TSC2 function in cell size regulation and cell survival treatment using concentrations between 20 and 100 mM
achieved 50 to 70% reduction of intracellular ATP levelsunder energy starvation conditions. Our studies demon-
strate an essential role of TSC2 and AMPK phosphoryla- and resulted in inhibition of S6K and 4EBP1 phosphory-
lation. They concluded that the inhibition of S6K andtion in the cellular energy response.
4EBP1 phosphorylation by 2DG is directly due to the
sensing of lowered ATP levels by mTOR, which has aResults
Km for ATP of around 1 mM (Dennis et al., 2001). We
observed that mannitol, an osmolite, at 100 mM alsoATP Depletion Induces TSC2 Phosphorylation
Protein synthesis is regulated by multiple cellular condi- significantly inhibited the phosphorylation of S6K (Figure
1C), suggesting that the effect of high concentration oftions including cellular energy levels. We observed that
depletion of cellular ATP by the glucose analog 2-deoxy- 2DG could be due to a mixed response of depletion of
cellular ATP level and its acting as an osmolite. Weglucose (2DG, which blocks cellular glucose utilization
by indirectly inhibiting hexokinase), mitochondrial un- observed that at low concentrations of 2DG, such as 25
mM, phosphorylation of S6K on T389 was effectivelycoupler FCCP, and the PKC inhibitor Rottlerin (Soltoff,
2001) caused a dephosphorylation of S6K and 4EBP1 inhibited while a similar concentration of mannitol had
little effect (Figure 1C). Similar observations were ob-(Figure 1A). In addition, depletion of nutrients by cultur-
ing cells in D-PBS inhibited the phosphorylation of S6K served with the phosphorylation of S6 and 4EBP1 (Fig-
TSC2 Is Activated by AMPK
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ure 1C). Phosphorylation of mTOR S2448, which may lates the interaction between endogenous TSC2 and
AMPK.correlate with mTOR activity (Nave et al., 1999; Scott et
al., 1998; Sekulic et al., 2000), was also inhibited by 25 We also performed coimmunoprecipitation studies
between endogenous AMPK and overexpressed TSC2mM 2DG (Figure 1C). In contrast, 25 mM 2DG had little
effect on Akt phosphorylation. These results demon- and confirmed that 2DG enhances the interaction be-
tween TSC2 and AMPK (Figure 2D). Deletion analysisstrate that 2DG specifically inhibits the phosphorylation
of S6K, 4EBP1, and mTOR but does not signal showed that the C-terminal domain of TSC2 is responsi-
ble for the interaction with AMPK while the N-terminalthrough Akt.
AMPK is much more sensitive to changes in cellular domain is not required.
energy status than mTOR because it is activated by
the ratio of AMP/ATP. 25 mM 2DG-activated AMPK as TSC2 Is Required to Mediate
indicated by the dramatic increase of T172 phosphoryla- the Cellular Energy Response
tion in AMPK (Figure 1D) (Hardie and Hawley, 2001). To determine the role of TSC2 in S6K inactivation by
2DG at 25 mM induced rapid AMPK activation and con- 2DG, HEK293 cells were treated with TSC2 RNAi oligos.
comitant dephosphorylation of S6K as a function of TSC2 RNAi significantly decreased endogenous TSC2
treatment time (Figure 1E). Our observations are consis- protein levels, but had no effect on the unrelated protein
tent with recent reports that AMPK activation closely MEK2 (Figure 3A). 2DG-induced S6K dephosphorylation
correlates with the inhibition on S6K and 4EBP1 (Horman was blocked in TSC2 knockdown cells, but not in the
et al., 2002; Kimura et al., 2003; Krause et al., 2002). control cells. In contrast, knockdown of TSC2 had no
These data suggest that activation of AMPK may be significant effect on AMPK phosphorylation in response
responsible for the ATP-depletion induced dephosphor- to 2DG. Inhibition of mTOR by rapamycin-blocked S6K
ylation of S6K and 4EBP1. We observed a statistically phosphorylation even when TSC2 expression was
significant reduction of ATP levels and an increase of knocked down suggesting that mTOR is downstream of
AMP/ATP ratio in cells treated with 25 mM 2DG (Sup- TSC2 (Figure 3B).
plemental Figures S1A and S1B available at http:// We further examined the function of AMPK in S6K
www.cell.com/cgi/content/full/115/5/577/DC1). However, regulation. Coexpression of the active AMPK I or II
based on previously published data, such a decrease in catalytic subunit resulted in a decrease of S6K phos-
ATP concentration would not significantly affect mTOR phorylation (Figure 3C), supporting that AMPK nega-
kinase activity (Dennis et al., 2001). This suggests that tively controls S6K phosphorylation. Knockdown of
AMPK is the prime energy sensor in response to mild TSC2 by RNAi blocked the inhibitory effect of AMPK
energy depletion. Glucose limitation also decreased expression, suggesting that TSC2 acts downstream of
S6K phosphorylation, increased AMPK phosphoryla- AMPK. Neither TSC2 RNAi nor rapamycin significantly
tion, and caused a mobility shift of TSC2 (Figure 1F). affected the phosphorylation of acetyl CoA carboxylase
(ACC) and eukaryote elongation factor 2 (eEF2), two
AMPK substrates (Supplemental Figures S2A and S2B2DG Stimulates the Interaction between
Endogenous AMPK and TSC2 available on Cell website), supporting the specific role
of TSC2 in mediating AMPK on S6K regulation.The fact that 2DG induces AMPK activation and a mobil-
ity upshift of TSC2 suggests that AMPK may be respon- If TSC2 plays a role in mediating S6K inhibition by
ATP depletion, EEF8 (TSC2/) and the EEF4 (TSC2/)sible for TSC2 phosphorylation. We first examined
whether AMPK and TSC2 interact. Immunoprecipitation fibroblasts should respond differently to various ATP
depletion reagents. As expected, EEF8 cells show aof AMPK indicated that both TSC1 and TSC2 are weakly
coimmunoprecipitated by AMPK (Figure 2A). TSC2 and much higher level of S6K phosphorylation (Figure 3D).
In order to compare the results of EEF4 and EEF8 cells,TSC1 were found to interact preferentially with AMPK
following 2DG stimulation. We also performed coimmu- both long and short exposures of the S6K phosphoryla-
tion immunoblot are presented in Figure 3D. We ob-noprecipitations with the anti-phospho AMPK antibody
(pAMPK), which recognizes the active form of AMPK. served that Rottlerin, FCCP, and to a lesser extent,
azide, oligomycin, and rotenone caused a decrease inInterestingly, this antibody specifically precipitated the
active, hence slower, migrating form of AMPK from both S6K phosphorylation in EEF4 cells. The effects of these
reagents on S6K phosphorylation are much weaker incontrol and 2DG-treated cell lysates (Figure 2A). How-
ever, no TSC2 or TSC1 was recovered in the anti-pAMPK EEF8 cells (Figure 3D). Similar results were observed
with the phosphorylation of 4EBP1. However, the activa-immunoprecipitates. This observation is not surprising
because T172 in AMPK is localized in the activation loop tion of AMPK was not different between the EEF4 and the
EEF8 cells (Figure 3D). These data further support the(Scott et al., 2002; Stein et al., 2000). Binding of antibody
to this site may block substrate binding based on known notion that TSC2 plays an important role in mediating
the effect of ATP depletion on the phosphorylation ofkinase structures.
To determine whether active AMPK is associated with S6K and 4EBP1. We performed similar experiments with
2DG and D-PBS treatment. In EEF8 (TSC2/) cells, 2DGTSC2, we performed reciprocal coimmunoprecipitation
with anti-TSC2 antibody followed by Western blotting and D-PBS had little effect on 4EBP1 phosphorylation.
This is in contrast to the inhibition of phosphorylationwith anti-AMPK and anti-pAMPK antibody. The interac-
tion between endogenous AMPK and TSC2 was en- of 4EBP1 in the EEF4 (TSC2/) cells (Figure 3E). Our
data are consistent with previously published observa-hanced by 2DG (Figure 2B). Figure 2C shows that the
levels of proteins in the lysates are similar. The above tions that nutrient depletion-induced S6K dephosphory-
lation is compromised in TSC2/ cells (Gao et al., 2002).observations demonstrate that 2DG treatment stimu-
Cell
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Figure 2. ATP Depletion Stimulates the Interaction of Endogenous AMPK and TSC2
(A) 2DG stimulates the coimmunoprecipitation between endogenous TSC2 and AMPK. HEK293 cells were treated with 25 mM 2DG for 2.5
min. Cell lysates were immunoprecipitated with anti-AMPK (N) or anti-phospho AMPK (P) antibody. The immunoprecipitates were blotted with
indicated antibodies for TSC2, TSC1, pAMPK, and AMPK. IP denotes immunoprecipitation. SE. and LE. denote short exposure and long
exposure, respectively.
(B) Reciprocal immunoprecipitation of endogenous TSC2 and AMPK. Cell lysates were subject to immunoprecipitation with anti-TSC2 antibody.
Preincubation of anti-TSC2 antibody with TSC2 peptide (Santa Cruz) was included as a control for the competition (comp).
(C) Expression levels of endogenous TSC1, TSC2, pAMPK, and AMPK in lysates of HEK293 cells.
(D) The C-terminal fragment of TSC2 interacts with endogenous AMPK. HEK293 cells were transfected with HA-TSC2 WT, HA-TSC2 N-terminal
(1–1080) and HA-TSC2 C-terminal (1005–1765). The cell lysates were immunoprecipitated with HA antibody followed by Western blot with
anti-HA or anti-pAMPK.
TSC2 Is Phosphorylated by AMPK support our hypothesis that AMPK activation plays an
important role in TSC2 phosphorylation and S6K inhibi-Treatment with lambda phosphatase converted TSC2
to a faster migrating band (Figure 4A), which suggests tion in response to energy starvation.
that the 2DG-induced mobility shift is due to phosphory-
lation. TSC1 is also a phosphoprotein, which is down- T1227 and S1345 in TSC2 Are Major AMPK
Phosphorylation Sitesshifted by lambda phosphatase treatment (Figure 4A).
However, 2DG treatment did not alter the mobility of To elucidate the mechanism of TSC2 regulation by
AMPK, we performed in vivo labeling and two-dimen-TSC1. Cotransfection of active AMPK I also induced
a mobility upshift of TSC2, but not of TSC1, suggesting sional phosphopeptide mapping of TSC2. Stimulation
with 2DG (25 and 40 mM) enhanced phosphorylation ofthat AMPK regulates TSC2 phosphorylation (Figure 4B).
Incubation of HEK293 cells with 10 M AMPK inhibitor several peptides (Figure 5A, a–c). Interestingly, coex-
pression of the active AMPK I subunit also increased(Zhou et al., 2001) increased the mobility of TSC2, sup-
porting a role for endogenous AMPK in TSC2 phosphor- phosphorylation of the same peptides stimulated by
2DG (Figure 5A, a and d). The shaded spots in Figureylation (Figure 4C).
The functional relationship between AMPK and 2DG- 5A, image e denote phosphopeptides induced by 2DG
or AMPK. These results clearly demonstrate that AMPKinduced S6K dephosphorylation was examined by ex-
pressing dominant-negative AMPK. Dose-dependent plays a major role in TSC2 phosphorylation induced
by 2DG.expression of the kinase inactive catalytic subunit II of
AMPK (AMPK-DN) partially blocked S6K inhibition by We searched the TSC2 sequence for AMPK recogni-
tion consensus sites (Hardie et al., 1998) and found that2DG treatment (Figure 4D). Furthermore, incubation of
HEK 293 cells with an AMPK inhibitor significantly re- rat TSC2 contains 8 putative AMPK sites (Supplemental
Figure S3 available on Cell website). We mutated allversed the inhibitory effect of 2DG on S6K phosphoryla-
tion (Figure 4E). AMPK inhibitor also significantly putative AMPK sites individually and performed two-
dimensional phosphopeptide mapping. Our data indi-blocked S6K dephosphorylation induced by glucose
deprivation (Figure 4F). Together, these data strongly cate that all the individual mutants, except for T1227A
TSC2 Is Activated by AMPK
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Figure 3. TSC2 Is Required for ATP Depletion-Induced Dephosphorylation of S6K
(A) Knockdown of TSC2 by RNA interference blocks the 2DG response. HEK293 cells were cotransfected HA-S6K and TSC2 RNAi as indicated.
Cells were stimulated with 2DG for 15 min. HA-S6K was immunoprecipitated with anti-HA antibody and Western blotted with anti-phospho
S6K(T389) and anti-HA.
(B) Knockdown of TSC2 by RNA interference does not block rapamycin-induced dephosphorylation of S6K. Experiments were similar to Figure
3A, except rapamycin (20 nM for 30 min preincubation) was used to treat the HEK293 cells.
(C) Inhibition of S6K by AMPK overexpression is blocked by TSC2 RNAi. HA-S6K was cotransfected with the active AMPK I or II subunit
as indicated. Cotransfection of TSC2 RNAi is indicated. HA-S6K was immunoprecipitated and phosphorylation of S6K was determined. The
expression of transfected HA-AMPK was also determined by Western blotting.
(D) ATP depletion-induced dephosphorylation of S6K and 4EBP1 are compromised in TSC2/ cells. EEF4 (TSC2/) and EEF8 (TSC2/) cells
were treated with various reagents for 15 min (rottlerin 10 M, FCCP 10 M, azide 1 mM, oligomycin 6.3 M, and rotenone 20 M).
Phosphorylation of endogenous S6K, 4EBP1, and AMPK was determined. Two different exposures (SE. short exposure, LE. long exposure)
of pS6K (T389) and p4EBP1(S65) are presented.
(E) 2DG-induced 4EBP1 dephosphorylation is compromised in TSC2/ cells. EEF4 and EEF8 cells were treated with 2DG (12.5 mM, 25 mM,
and 50 mM) in DMEM/F12 medium or D-PBS for 30 min. Phosphorylation of 4EBP1 was determined.
and S1345A, had phosphopeptide maps similar to the the in vitro phosphorylation of TSC2 by AMPK, indicating
that S1345 is a direct AMPK phosphorylation site. Thesewild-type TSC2 (data not shown). Interestingly, the
S1345A mutant affected the majority of the 2DG and data also suggest that S1337 and S1341 are not direct
AMPK phosphorylation sites (Figure 5C) although phos-AMPK inducible phosphopeptides (spots 1–3, 5–8 in
image f, Figure 5A). These results support the hypothesis phorylation of these residues is enhanced by 2DG and
AMPK in vivo (Figures 5A and 5B). Mixing of in vitrothat S1345 is likely an AMPK phosphorylation site in
vivo. Furthermore, phosphorylation of S1345 may affect phosphorylated TSC2 fragment with the in vivo phos-
phorylated TSC2-S1345A mutant demonstrate that thephosphorylation of other residues, such as S1337 and
S1341, which are adjacent to the AMPK, site S1345 in vitro AMPK phosphorylation sites in TSC2 are indeed
phosphorylated in vivo (Figure 5D). We also observed(Figure 5B).
To confirm whether S1345 can be phosphorylated by that T1227 is phosphorylated by AMPK (Supplemental
Figure S4 available on Cell website).AMPK directly in vitro, a TSC2 fragment containing
S1345 was expressed and purified (Figure 5C). The TSC2 Mutation of S1345 affected multiple phosphorylation
sites including S1337 and 1341 even though these arefragment was phosphorylated by immunoprecipitated
AMPK, but not the kinase inactive AMPK mutant (Figure not AMPK consensus (Figures 5A and 5B). We created
the TSC2-S1337/1341/1345A (TSC2-3A) triple mutant5C, top image). Mutation of S1345 to either alanine
(S1345A) or aspartate (S1345D) completely eliminated and tested the mobility shift induced by 2DG. The 2DG
Cell
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Figure 4. ATP Depletion and AMPK Induce TSC2 Phosphorylation
(A) 2DG-induced TSC2 mobility shift is due to phosphorylation. HA-TSC2 and Myc-TSC1 were transfected into HEK293 cells and treated with
25 mM 2DG for 15 min as indicated. Cell lysates were treated with lambda phosphatase to determine phosphorylation state.
(B) Active AMPK I expression induces a slow migrating form of TSC2.
(C) An AMPK inhibitor blocks the 2DG induced mobility shift of TSC2. AMPK inhibitor (Compound C, 10 M) was added 30 min before the
treatment of 2DG as indicated.
(D) Kinase inactive AMPK mutant blocks 2DG-induced dephosphorylation of S6K. HEK293 cells were transfected with increasing amounts of
the kinase inactive AMPK mutant (AMPKDN). Phosphorylation of cotransfected HA-S6K was determined.
(E) AMPK inhibitor blocks the 2DG-induced dephosphorylation of S6K. HEK293 cells were treated with AMPKI (10 M) for 30 min prior to the
addition of 2DG. Phosphorylation of endogenous S6K and Akt was determined.
(F) AMPK inhibitor partially blocks S6K dephosphorylation induced by glucose deprivation. HEK293 cells were cultured in media with indicated
concentration of glucose for 2 hr in the presence or absence of AMPK inhibitor (10 M).
dependent upshift was largely abolished in the triple infected EEF8 (TSC2/) fibroblast cells with a retrovirus
expressing either the wild-type or the T1227A/S1345Amutant (Figure 5E), indicating that these residues are
major phosphorylation sites induced by energy star- mutant. As expected, expression of TSC2 reduced the
basal phosphorylation of S6K and 4EBP1 (Figure 6C).vation.
Treatment with 2DG caused little decrease of S6K and
4EBP1 phosphorylation in the vector-infected cells. InAMPK Phosphorylation Enhances TSC2 Function
The functional significance of AMPK phosphorylation contrast, 2DG significantly decreased S6K and 4EBP1
phosphorylation in wild-type TSC2-expressing cellswas assessed by using TSC2 phosphorylation mutants.
HEK 293 cells transfected with TSC2-3A mutant showed (Figure 6C). Interestingly, cells expressing the TSC2–
T1227A/S1345A mutant were less responsive to 2DGthat this mutant was less able to inhibit S6K in response
to 2DG treatment (Figure 6A). This result is consistent treatment than those expressing wild-type TSC2 (Figure
6C). These data support a model that the AMPK-depen-with the notion that phosphorylation by AMPK promotes
the ability of TSC2 to inhibit S6K. We also tested the dent phosphorylation of T1227 and S1345 in TSC2 plays
an important role in the cellular response to 2DGability of TSC2-3A to interact with TSC1 and found that
the mutant TSC2 was able to form a complex with TSC1 treatment.
To further establish the functional importance of TSC2normally (Figure 6B).
To examine whether phosphorylation of TSC2 by and AMPK phosphorylation in response to changes in
the cellular energy, we established stable TSC2-express-AMPK plays a role in the dephosphorylation of S6K and
4EBP1 in response to 2DG treatment, we transiently ing cell lines from the TSC2/ LEF cells that are derived
TSC2 Is Activated by AMPK
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Figure 5. AMPK Phosphorylates TSC2 on S1345
(A) 2DG and AMPK induce TSC2 phosphorylation on multiple spots in vivo. HA-TSC2 was cotransfected with TSC1 in HEK 293 cells. Cells
were labeled with 32P-phosphate. HA-TSC2 was analyzed by a two-dimensional phosphopeptide mapping. Phosphopeptides of basal (a),
treatment with 2DG (b and c), active AMPK I subunit cotransfection (d), and the TSC2-S1345A mutant with 2DG treatment (f) are indicated.
Image e is a schematic representation of phosphopeptides. The shaded spots denote those that are increased by 2DG treatment or AMPK
cotransfection. The arrowhead indicating S939 (Akt phosphorylation spot) is used as a reference marker.
(B) S1337 and S1341 are AMPK-dependent sites phosphorylated by 2DG treatment. Two-dimensional phosphopeptide mapping of wild-type
and TSC2-A1337A/S1341A mutant. Spot 2 and 8 are missing in the mutant. Furthermore, a new spot appears in the mutant as indicated by
an arrowhead.
(C) AMPK directly phosphorylates TSC2 on S1345 but not S1337 or 1341 in vitro. The TSC2 fragment (residues 1300–1367) was expressed
as a GST fusion (GST-TSC2 F1) and purified from E. coli. Wild-type AMPK I (WT) or the kinase inactive AMPK I (KD) plasmids were
transfected into HEK293 cells and immunoprecipitated. GST-TSC F1 was phosphorylated in vitro by immunoprecipitated AMPK and detected
by autoradiography (top image). Coomassie blue staining of the recombinant TSC2 F1 is shown in the middle image. The amount of AMPK
used in the kinase assay is shown in the bottom image. S1345A and S1345D denote mutations of Ser1345 in TSC2 F1 replaced by alanine
and aspartate, respectively.
(D) Ser1345 in TSC2 is phosphorylated in vivo. Two-dimensional phosphopeptide mapping of in vivo label and in vitro phosphorylated TSC2.
Mutation of S1345 resulted in elimination of multiple phosphopeptide spots, including spots 3 and 6 (a and b). Image c is the 2-D map of the
in vitro phosphorylated TSC2 by AMPK. Image d, 2-D map of the mixture of in vivo labeled TSC2-S1345A and the in vitro phosphorylated
TSC2 F1.
(E) Wild-type TSC2 but not the S1337A/S1341A/S1345A (3A) mutant shows a mobility shift in response to 2DG. EEF8 (TSC2/) cells were
infected with retrovirus encoding the TSC2 or TSC2-3A, and treated with 2DG as indicated.
from an epithelial origin. Expression of TSC2 decreased deprivation. Furthermore, phosphorylation of TSC2 by
AMPK is required for the cellular response to energy limi-S6K phosphorylation while expression of the TSC2-3A
had a much weaker effect on S6K (Figure 6D). Impor- tation.
tantly, glucose deprivation decreased in S6K phosphor-
ylation in the wild-type TSC2-expressing cells, but had TSC Protects Cells from Glucose
Deprivation-Induced Apoptosisa much smaller effect in the vector or the TSC2-3A-
expressing cells even though AMPK activation was un- To determine the physiological relevance of TSC2 in
energy sensing pathway, we examined the effect of en-affected (Figure 6E). These results clearly demonstrated
that TSC2 is required for S6K inactivation by glucose ergy starvation on cell viability. We found that the vector-
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Figure 6. AMPK Phosphorylation Is Important for TSC2 Function in the Regulation of S6K Phosphorylation in Response to Energy Starvation
(A) Mutation of the AMPK-dependent sites in TSC2 decreases TSC2 activity. HEK293 cells were transfected with wild-type or mutant TSC2
as indicated. The anti-pS6K(T389) blot was exposed for longer time in the right image.
(B) Mutant TSC2 can form complex with TSC1.
(C) Cells expressing the AMPK phosphorylation mutant TSC2 (T1227A/S1345A) are less responsive to 2DG treatment. The EEF8 (TSC2/
fibroblast) cells were transiently infected with wild-type or mutant TSC2 retrovirus as indicated. Phosphorylation of endogenous S6K and
4EBP1 was determined. The arrow indicates the expression of wild-type and mutant TSC2, which just below the nonspecific band detected
by anti-TSC2.
(D) TSC2-3A mutant is less active to inhibit S6K. LEF (TSC2/ epithelial) cells were infected with TSC2 retrovirus and selected for the
neomycin-resistant stable-expressing cells. Expression of TSC2 was determined by immunoprecipitation and Western blot with anti-TSC2
antibody. Phosphorylation of endogenous S6K was determined.
(E) The AMPK-dependent phosphorylation of TSC2 is important for glucose deprivation-induced S6K dephosphorylation. Stable LEF cells
infected with vector, TSC2, and TSC2-3A were cultured in the presence (25 mM) or absence of glucose for 16 hr. Phosphorylation of endogenous
S6K and AMPK was determined.
infected LEF cells underwent massive cell death 72 hr 3 activation in the TSC2/ and TSC2-3A-expressing
cells (Figure 7D). We also tested the effect of energyafter shifting to glucose-free conditions (Figure 7A). In
contrast, the TSC2-expressing LEF cells showed little deprivation in the other cell lines, including TSC2/
EEF8 cells (fibroblast) and TSC1/ MEF cells. We ob-increase in cell death, suggesting that TSC2 rescued
cell death by glucose starvation (Figure 7A). To deter- served that glucose deprivation induced apoptosis in
both TSC2/ EEF8 (Figures 7E and 7F) and TSC1/mine the significance of AMPK phosphorylation in TSC2
function, we also examined the TSC2-3A-expressing MEF cells (Figures 7G and 7H). These results indicate
that both TSC1 and TSC2 play an essential role in cellularLEF cells. Interestingly, TSC2-3A failed to protect LEF
cells from glucose deprivation-induced cell death (Fig- energy response.
ure 7A). Furthermore, rapamycin treatment almost com-
pletely suppressed glucose deprivation-induced cell Cell Size Regulation by ATP Depletion and TSC2
TSC2 has been demonstrated to play a critical role indeath in LEF (Vec) and LEF (3A) cells (Figure 7A). These
data suggest that the uncontrolled high mTOR activity cell size control in Drosophila. We observed that the
knockdown of TSC2 by RNAi resulted in a reproducibleis responsible for cell death under energy starvation
conditions. increase in HEK293 cell size even though the effect is
small (Figure 8A). The small effect of RNAi on cell sizeWe performed experiments to examine whether glucose
deprivation induces apoptosis. A fluorescence-based could be due to an incomplete elimination of TSC2 by
RNAi. We found that 2DG treatment significantly de-assay for DNA fragmentation showed that glucose dep-
rivation induced apoptosis in vector and TSC2-3A, but creased cell size (Figure 8A). Knockdown of TSC2 by
RNAi partially blocked the cell size decrease inducednot in TSC2-expressing LEF cells (Figure 7B). Western
blots for apoptosis markers revealed that both caspase by 2DG. The cell size effects of TSC2 RNAi and 2DG
are cell cycle independent as these treatments similarly3 and PARP were cleaved during glucose deprivation
(Figure 7C). Rapamycin treatment suppressed caspase affect both G1 and G2 cells. These results demonstrate
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Figure 7. TSC2 Plays Essential Roles in Protecting Cells from Glucose Depletion-Induced Apoptosis
(A) TSC2 and rapamycin, but not TSC2-3A, protect LEF cells from glucose depletion-induced cell death. LEF cells stably expressing vector,
TSC2, or TSC2-3A were cultured in 25 mM glucose (G) or glucose-free medium (G-) with or without 20 nM rapamycin. Pictures were taken
at 72 hr in culture. Note that the TSC2 wild-type expressing cells are morphologically smaller.
(B) Glucose depletion induces DNA fragmentation in vector and TSC2-3A but not in TSC2-expressing LEF cells. Cells were cultured in glucose-
free medium for 48 hr. Both floating and attaching cells were harvested and histone-associated DNA fragmentation was measured.
(C) Glucose depletion induces cleavage of caspase-3 and PARP in vector and TSC2-3A but not in TSC2-expressing LEF cells. Western blot
with caspase-3 and PARP antibody was performed.
(D) Rapamycin inhibits glucose depletion-induced caspase-3 activation in LEF cells. LEF cells stably expressing vector, TSC2, or TSC2-3A
were cultured in glucose-free medium with or without 20 nM rapamycin for 48 hr. Western blots with anticleaved-caspase-3 and actin
were shown.
(E) Effect of glucose depletion on cell death in EEF8 (TSC2/) and EEF4 (TSC2/) cells. EEF cells were cultured in glucose-free medium with
or without 20 nM rapamycin for 96 hr.
(F) Effect of glucose depletion on caspase-3 activation in EEF cells. The EEF4 and EEF8 cells were cultured in glucose-free medium with or
without 20 nM rapamycin for 72 hr. Western blots with cleaved-caspase-3 and actin were shown.
(G) Effect of glucose depletion on cell death in MEF (TSC1/) and MEF (TSC1/) cells. The MEFs were cultured in glucose-free medium for
48 hr.
(H) Effect of glucose depletion on caspase-3 activation in MEF (TSC1/) and MEF (TSC1/) cells. MEFs were cultured in glucose-free medium
with or without 20 nM rapamycin for 16 hr. Experiments were same as Figure 7F.
that TSC2 plays an important role in 2DG-induced cell size as previously reported (Figures 8A and 8B) (Fingar
et al., 2002). These data are consistent with that TSC2size reduction.
The effect of glucose starvation on cell size was also mediates the energy limitation signal to regulate cell
size.investigated. HEK293 cells cultured in 2.8 mM glucose
(normal medium has 25 mM glucose) for 72 hr showed We observed that TSC2-expressing LEF cells are sig-
nificantly smaller than the vector- or TSC2-3A-express-a significant reduction of cell size (Figure 8B). This result,
together with the 2DG experiment described above, ing cells (Figure 7A). FACS analysis studies confirmed
that expression of TSC2 decreased the size of LEFdemonstrates that cellular energy starvation decreases
cell size. Treatment with rapamycin also decreased cell TSC2/ cells (Figure 8C). Interestingly, TSC2-3A showed
Cell
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Figure 8. TSC2 Plays Critical Roles for Cell Size Control in Response to Energy Starvation
(A) 2DG decreases cell size in HEK293 cells. HEK293 cells were cultured in the presence of 12.5 mM 2DG, TSC2 RNAi, or 20 nM rapamycin
for 72 hr. Cells were harvested and FACS analysis was performed to determine cell size. The X-axis indicates relative cell size. Cell size
distribution curve of the control, as indicated by the gray curve, is included in each image for comparison purpose.
(B) Low glucose (2.8 mM) decreases cell size in HEK293 cells. Experiments are similar to those in (A).
(C) TSC2-3A is defective in cell size regulation. LEF cells stably expressing TSC2, TSC2-3A, and vector control were subjected to FACS
analysis for cell size determination.
(D) The AMPK dependent phosphorylation of TSC2 is required for the function of TSC2 in cell size regulation by energy starvation. The TSC2/
LEF cells stably expressing TSC2, TSC2-3A, and vector were cultured in 25 mM (upper images) or 1 mM glucose (lower images) containing
media for 96 hr as indicated. Cells were harvested and FACS analysis was performed. Cell size distributions of G1 population are shown.
(E) A proposed model of TSC2 in cellular energy-signaling pathway. TSC2 receives signals from AMPK, which directly sensing cellular AMP/
ATP ratio, to inhibit mTOR signaling. This model predicts that TSC1/TSC2 plays an important physiological function to control protein synthesis,
cell size, and cell viability in response to cellular energy levels.
a lessened ability to reduce cell size in the LEF TSC2/ cant cell size reduction by energy starvation (Figure 8D).
In contrast, the TSC2-3A-expressing cells did not re-cells when compared to wild-type TSC2, supporting that
AMPK phosphorylation increases TSC2 function. store normal cellular energy response and behaved
indistinguishably from the TSC2/ cells. Energy starva-To demonstrate the physiological relevance of AMPK
phosphorylation of TSC2 in cell size control, we exam- tion caused a significant cell size increase of the TSC2-
3A-expressing cells (Figure 8D). The above data demon-ined the effect of glucose limitation on cell size. We
tested various concentrations of glucose and found that strate that the AMPK dependent phosphorylation plays
an essential role for the physiological functions of TSC21 mM glucose is the lowest concentration that does not
induce significant apoptosis in the TSC2/ LEF cells. to regulate cell size in response to cellular energy starva-
tion. A possible explanation for the cell size increase inFACS analyses showed that 1 mM glucose did not re-
duce cell size of the TSC2/ LEF cells (Figure 8D). the TSC2/ cells is that the TSC2/ cells are unable
to respond to energy starvation and continue to growInterestingly, 1 mM glucose significantly increased cell
size of the TSC2/ cells. These observations demon- despite of the low energy levels. However, energy limita-
tion may prevent cell cycle progression by activatingstrate that TSC2 plays an important role in cell size
control in response to energy starvation. The TSC2- and cell cycle checkpoints. Therefore, the TSC2/ and the
TSC2-3A-expressing cells are increased in cell size un-TSC2-3A-expressing cells were also cultured in 1 mM
glucose. As expected, expression of wild-type TSC2 der low glucose conditions but will die under glucose-
free conditions. These observations are completely con-restored the normal cellular energy response, a signifi-
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sistent with our model that TSC2 plays an essential role TSC-mTOR pathway plays a major role in regulation of
cell survival under energy starvation conditions.in the coordination between cell growth and cellular
The function of TSC2 in the cellular energy responseenergy levels.
is further supported by the fact that energy limitation
by glucose deprivation or 2DG treatment decreases cellDiscussion
size. Consistently, TSC2 expression also reduces cell
size. Therefore, energy limitation and TSC2 have similarThe coordination between cell growth and cellular en-
effects on cell size control. The energy starvation-ergy levels is a fundamental question in cell biology and
induced cell size reduction is abolished in TSC2/ cells.has not been fully understood. This study provides a
Expression of wild-type, but not the AMPK phosphoryla-molecular mechanism how cellular energy starvation ac-
tion mutant TSC2, restores the energy starvation-tivates TSC2, which then inhibits cell growth and en-
induced cell size reduction. These observations clearlyhances cell survival by inhibiting translation (Figure 8E).
established the physiological importance of AMPKTherefore, TSC2 is an essential player in the coordina-
phosphorylation of TSC2 in cellular energy response. Ittion of cellular energy levels and cell growth or survival.
is conceivable that the activation of TSC2 by AMPK-Our model predicts that AMPK is a cellular energy sen-
dependent phosphorylation results in a decrease ofsor and activates TSC2 by direct phosphorylation.
protein synthesis and conservation of cellular energymTOR is a key downstream target of TSC2 to mediate
(Figure 8E). Consistent with this model, rapamycin sig-the cellular response (Figure 8E).
nificantly protects LEF cells from glucose deprivation-Protein synthesis is a major cellular process regulated
induced apoptosis. The inability of TSC2/ cells to sup-by a wide array of intracellular and extracellular condi-
press translation initiation under the energy starvationtions such as mitogenic growth factors, amino acid con-
condition could produce the detrimental effects and trig-centrations, and cellular energy levels. Protein synthesis
ger apoptosis.utilizes approximately 20%–25% of the total cellular en-
The identification of TSC2 as an important physiologi-ergy and must be tightly coordinated with cellular energy
cal substrate of AMPK may provide a mechanism ofstatus (Schmidt, 1999). Inhibition of translation is a major
AMPK mutation in human disease. AMPK subunits mu-physiological response under energy starvation condi-
tations have been implicated in familial hypertrophictions to maintain homeostasis. One of the major transla-
cardiomyopathy (Hardie and Hawley, 2001). TSC2 ho-tion controls is mediated by the phosphorylation of S6K
mozygous mutation shows a lethal phenotype with car-and 4EBP1 by mTOR (Proud, 2002). In this study, we
diac hypertrophy. Furthermore, inhibition of mTOR bydemonstrated that TSC2 plays an important physiologi-
rapamycin has been documented in the suppressioncal role to inhibit mTOR signaling in response to cellular
of cardiac hypertrophy (Shioi et al., 2003). TSC2 is aenergy levels (Figure 7G). Phosphorylation of TSC2 by
prominent negative regulator of cell size control in Dro-AMPK stimulates TSC2 activity to inhibit S6K and 4EBP1
sophila (Potter and Xu, 2001) and in mammalian cellsphosphorylation. In contrast, phosphorylation of TSC2
from this study. All these observations are consistentby Akt relays the growth factor signals and suppresses
with our model that TSC2 acts downstream of AMPK to
the activity of TSC2. Our results demonstrate that the
inhibit mTOR. This may suggest a possible mechanistic
AMPK-dependent phosphorylation of TSC2 is required
role of TSC2 in mediating the function of AMPK in car-
for ATP depletion-induced dephosphorylation of S6K
diac hypertrophy.
and 4EBP1. LKB1 is a tumor suppressor gene and mutation of
Based on our model, mTOR is in the energy-sensing LKB1 is responsible for the Peutz-Jeghers syndrome
pathway downstream of TSC1/TSC2 (Figure 8E). How- (Hemminki et al., 1998; Jenne et al., 1998). The molecular
ever, AMPK is likely the cellular energy sensor under mechanism for LKB1 as a tumor suppressor has been
most physiological and pathological conditions and unclear because key physiological substrates of LKB1
functions upstream of TSC1/TSC2. Under extreme en- were previously unknown. It has been recently demon-
ergy starvation conditions, mTOR may also function as strated that LKB1 is the upstream activating kinase for
a cellular energy sensor. AMPK can inhibit translation AMPK (Hong et al., 2003; Sutherland et al., 2003; Hawley
by at least two mechanisms, one by phosphorylation of et al., 2003). LKB1 directly phosphorylates AMPK in the
the eukaryotic elongation factor 2 (eEF2) (Horman et al., activation loop and increases AMPK kinase activity.
2002) and the other by phosphorylation of TSC2. We Peutz-Jeghers syndrome is characterized by multiple
propose that activation of AMPK plays a major role in hamartomas mainly in the intestine. Interestingly, the
the inhibition of protein synthesis by suppressing the hamartomas in Peutz-Jeghers syndrome are similar to
functions of multiple translation regulators including the benign tumors seen in TSC, although the tumors
S6K, 4EBP1, and eEF2 in response to energy starvation develop in different tissues (Yoo et al., 2002). These
and low metabolic conditions. Glucose deprivation in- observations taken together with our findings described
duces massive apoptosis in TSC2/ cells. Expression in this paper suggest one possible molecular mecha-
of wild-type TSC2 completely blocks apoptosis while nism for the tumor suppressor functions of LKB1, where
expression of the TSC2-3A mutant fails to protect cells the LKB1 tumor suppressor may activate the TSC2 tu-
from apoptosis. Similarly, glucose starvation also in- mor suppressor via the AMPK.
duces apoptosis in TSC1/ cells. Furthermore, mTOR In conclusion, our data demonstrate that TSC2 plays
is a key downstream target of TSC1/TSC2 because inhi- an important role in the coordination between cellular
bition of mTOR by rapamycin significantly suppressed energy levels, and cell growth and survival. TSC2 inte-
energy starvation-induced apoptosis in TSC2/ and grates signals from multiple pathways to regulate trans-
lation, cell size, and apoptosis. Activation of TSC2 byTSC1/ cells. These observations demonstrate that the
Cell
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Immunoprecipitations and Kinase AssayAMPK-dependent phosphorylation prepares cells for an
Cells were lysed in lysis buffer N (10 mM Tris-HCl [pH 7.5], 100 mMunfavorable growth environment and results in protec-
NaCl, 1% NP-40, 50 mM NaF, 2 mM EDTA, 1 mM DTT, 1 mM PMSF,tion from cell death. In addition to causing tuberous
10g/ml leupeptin, and 10g/ml aprotinin) and immunoprecipitated
sclerosis, inactivation of the TSC1/TSC2 tumor suppres- with HA antibody and protein G-Sepharose beads (Amersham Bio-
sor complex could be a key event in oncogenic path- sciences). Immunocomplexes were subjected to SDS-PAGE. To
study the interaction between TSC2 and AMPK, HEK 293 cells wereways and cellular hypertrophy.
harvested in the buffer I (20 mM Tris-HCl [pH 7.5], 20 mM NaCl, 1
mM EDTA, 5 mM EGTA, 20 mM -glycerophosphate, 1 mM DTT, 1
Experimental Procedures mM PMSF, 10 g/ml leupeptin, and 10 g/ml aprotinin) and soni-
cated. The cell lysates were immunoprecipitated with the indicated
Materials antibodies and immobilized protein A (PIERCE). Immunocomplexes
Anti-TSC2 (C-20) was from Santa Cruz Biotechnology. Anti-TSC1 were washed twice with buffer I containing 0.5 M NaCl and then
antibody was generously provided by Dr. Y. Xiong (University of washed twice with buffer II (10 mM HEPES [pH 7.4], 50 mM NaCl,
North Carolina). All another antibodies were from Cell Signaling. 20 mM -glycerophosphate, and 20 mM NaF) and then subjected
Human TSC1 (Myc-TSC1), rat TSC2 (HA-TSC2), and rat S6K1- II to SDS-PAGE.
(HA-S6K) constructs were described previously (Inoki et al., 2002). For the AMPK kinase assays, HEK293 cells were transfected with
The cDNAs encoding human AMPK I and  II subunit were obtained AMPK I or AMPK I D159A (kinase inactive) constructs. Trans-
by PCR and subcloned into pcDNA3-HA vector. To generate GST- fected HEK 293 cells were treated with 50 mM 2DG for 30 min and
fusion of TSC2, TSC2 fragments were expressed in pGEX-KG vector. then lysed in lysis buffer A (50 mM Tris-HCl [pH 7.5], 50 mM NaF,
All mutant constructs of TSC2, GST-fusion TSC2 fragments, AMPK 5 mM pyrophosphate, 1 mM EDTA, 1 mM DTT, 10% glycerol, 1%
(AMPK I D159A, AMPK I aa.1-314 T174D, AMPK II D157A, and Triton X-100, 1 mM PMSF, 10 g/ml leupeptin, and 10 g/ml aproti-
AMPK II aa.1-313 T172D) were created by PCR mutagenesis and nin) and immunoprecipitated by HA antibody and protein G-Sepha-
were verified by DNA sequencing. Compound C (AMPK inhibitor) rose beads. The immunoprecipitates were washed twice with buffer
was obtained from MERCK. A and then washed twice with buffer B (50 mM HEPES [pH 7.5],
1 mM EDTA, 1 mM DTT, 10% glycerol) and once with buffer N and
once with HEPES buffer (25 mM HEPES [pH 8], 0.5 mM EDTA,Cell Culture, Stimulation, Transfection,
0.025% -mercaptoethanol). Immunoprecipitated AMPK and AMPKand Retrovirus Infection
kinase inactive were subjected to a kinase assay using purifiedHEK293 cells, TSC1/, and TSC1/ MEF cells were cultured in
bacterial-derived TSC2 fragments as substrates.Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen) con-
taining 10% fetal bovine serum (FBS) (Invitrogen). For ATP depletion,
the cells were stimulated by 2DG and various other ATP-depletion
Cell Size and Cell Viability Assayreagents. One hour prior to stimulation, the culture media were
To determine cell size and DNA content, FACS analysis with Cellreplaced with serum-free DMEM containing 25 mM D-glucose. The
Quest software was performed. For HEK293 cell size experiments,cells were then stimulated by the 10 2DG solutions in DMEM for
confluent cells in 10 cm dish were replated to 10 cm dish (1:10–20indicated time. For glucose starvation, the cells were cultured with
split). After 16 hr, the cells were cultured under indicated conditionsD-glucose-free DMEM containing 25 mM HEPES and 10% dialyzed
for 72 hr. The cultured medium was changed every 24 hr. To harvestFBS. Transfections were performed in serum-free condition using
cells, plates were washed once phosphate saline buffer (PBS) andlipofectamine reagent (Invitrogen). EEF126-4 (EEF4, TSC2/),
incubated at 37	C for 2 min in 2 ml trypsin-EDTA. Cells were gentlyEEF126-8 (EEF8, TSC2/) and LExF2 (LEF) (TSC2/) cells were
pipetted off the plate with PBS/10% FBS, transferred to 15 ml coni-cultured in DMEM/F12 (Invitrogen) containing 10% FBS. The wild-
cal tubes, centrifuged for 3 min at 1000 rpm, once washed withtype or mutant rat TSC2 cDNA was subcloned into the retroviral
PBS/1% FBS, and the final cells pellets were resuspended with 1 mlvector pPGS-CMV-CITE-Neo. The Phoenix retrovirus packaging
of PBS/1% FBS. Resuspended cells were fixed on ice by addingcells were transfected with the empty retrovirus vectors or the vector
cold 3 ml of 100% ethanol (75% final). Fixed cells were stored atcontaining TSC2 or TSC2 mutants using lipofectamine reagent (In-
4	C until the time of analysis. Immediately before analysis on FACS,vitrogen). Forty hr after transfection, the retrovirus generated by the
the fixed cells were centrifuged at 1500 rpm for 3 min washed oncePhoenix cells was used for infection of EEF8 and LEF.
with PBS/1% FBS, and then incubated at 37	C for 20 min in 1 ml
of PBS/1% FBS containing 0.1% Triton X-100 and 250 g/ml
Nucleotides Measurement and Statistical Analysis RNAase A. The cells were stained by propidium iodide for FACS
HEK 293 cells cultured in a 12-well dish were treated with the indi- analysis to determine the cells size in G1-phase and G2-phase popu-
cated concentrations of 2DG for 15 min. The cells were scraped into lations. For LEF cells size analysis, completely trypsinized cells were
the buffer (100 mM Tris-HCl [pH 7.75], 4 mM EDTA) and immediately seeded to 10 cm dish at 20% confluency and then cultured with
frozen in liquid nitrogen. The frozen cells were lysed by boiling for DMEM/F12 5% FBS in the presence or absence of 20 nM rapamycin
5 min and then placed on ice for 5 min before the ATP levels in the for indicated hours. The cells were analyzed by FACS as de-
supernatants were measured using a luciferase-based assay (ATP scribed above.
Bioluminescence Assay Kit CLS II, Roche). To determine the ratio For DNA fragment assay, LEF cells were cultured with DMEM/
of AMP/ATP, the cellular concentrations of AMP and ATP were 10% dialyzed FBS in the presence or absence of 25 mM D-glucose
measured by high-pressure liquid chromatography (HPLC). For sta- for 48 hr. To detect apoptotic cell death, the mono- and oligonucleo-
tistical analysis, differences between groups were assessed by somes in cytoplasmatic fraction of cell lysates were determined by
ANOVA or Student’s t-test followed by Bonferroni’s post hoc com- ELISA using cell death detection ELISAplus Kit (Roche).
parison between selected groups.
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